https://www.selleckchem.com/pr....oducts/gsk2830371.ht
Rationale There is a need to minimize oral corticosteroid (OCS) use in patients with asthma to prevent their costly and burdensome adverse effects. Current guidelines do not provide recommendations for OCS tapering in patients with asthma.Objectives To develop expert consensus on OCS tapering among international experts.Methods A modified Delphi method was used to develop expert consensus statements relating to OCS use, tapering, adverse effects, adrenal insufficiency, and patient-physician shared decision-making. Initial statements
Like
Comment
Share
